Cultivating Wellness: India Expands National Push for Sustainable Medicinal Plants to Secure Supply Chains and Boost Rural Economies

Published July 22, 2026

DELHI — In an effort to strengthen public health infrastructure, preserve biodiversity, and bolster agrarian livelihoods, the Indian Ministry of Ayush has released a comprehensive progress report detailing multi-million rupee investments into the national medicinal plant sector.

According to official disclosures presented to the Rajya Sabha on July 21, 2026, by Union Minister of State (Independent Charge) for Ayush, Shri Prataprao Jadhav, the government is executing a multi-pronged strategy through the National Medicinal Plants Board (NMPB). The initiatives focus on conserving wild flora, establishing rigid supply chain standards, and incentivizing local farmers to cultivate essential botanical species.

This public health and agricultural push comes at a time when global demand for botanical therapeutics, natural health products, and traditional medicine systems (such as Ayurveda, Unani, and Siddha) is reaching unprecedented levels.

The Strategy: Conservation, Cultivation, and Quality Assurance

The cornerstone of this initiative is the Central Sector Scheme on “Conservation, Development, and Sustainable Management of Medicinal Plants.” Designed to span wild forests and agricultural fields, the policy bridges ecological preservation with modern supply-chain management.

                  ┌─────────────────────────────────────────┐
                  │      NATIONAL MEDICINAL PLANTS BOARD    │
                  └────────────────────┬────────────────────┘
                                       │
         ┌─────────────────────────────┼─────────────────────────────┐
         ▼                             ▼                             ▼
┌─────────────────┐           ┌─────────────────┐           ┌─────────────────┐
│ WILD CONSERVATION│           │  FARMER SUPPORT │           │ SUPPLY & MARKET │
│  (In & Ex-situ) │           │  (MIDH & RCFCs) │           │  (Integrations) │
└────────┬────────┘           └────────┬────────┘           └────────┬────────┘
         │                             │                             │
         ▼                             ▼                             ▼
• Forest regeneration          • High-yield seeds            • Local processing
• Community oversight          • GAP & GFCP training         • Value-addition
• Gene pool preservation       • Subsidies (40-50%)          • Warehousing hubs

1. In-Situ and Ex-Situ Conservation

Wild habitats are vulnerable to over-harvesting. To mitigate ecological degradation while protecting plant genetics, the NMPB has funded 15 major forest-conservation projects over the last five years, allocating ₹3,363.24 lakhs ($4.0M USD equivalent). These funds support:

• In-situ conservation: Protecting medicinal plants within their natural ecosystems.

• Ex-situ conservation: Cultivating and preserving species outside natural habitats, such as in botanical gardens and seed banks.

• Community partnerships: Collaborating with Joint Forest Management Committees (JFMCs), Biodiversity Management Committees (BMCs), and local Self-Help Groups (SHGs).

2. Standardizing Good Agriculture and Collection Practices

To bridge the gap between traditional foraging and pharmaceutical-grade manufacturing, the NMPB operates Regional-cum-Facilitation Centres (RCFCs) across the country. These centers distribute Quality Planting Material (QPM) to agriculturalists while training growers in Good Agriculture Practices (GAPs) and Good Field Collection Practices (GFCPs).

Between FY 2021–22 and FY 2025–26, the NMPB approved 152 educational projects—spanning workshops, farmer seminars, and training modules—backed by an approved outlay of ₹1,186.91 lakhs.

3. Supply Chain Integration and Direct Subsidies

Recognizing that agricultural production fails without processing infrastructure, the NMPB supported 12 supply-chain integration projects between 2023 and 2026 across states like Andhra Pradesh, Jammu & Kashmir, Uttarakhand, Tamil Nadu, and Uttar Pradesh. Furthermore, in coordination with the Ministry of Agriculture & Farmers Welfare, short-duration medicinal crops are being subsidized under the Mission for Integrated Development of Horticulture (MIDH).

(Note: Standard cost norm established at ₹1.50 Lakh per hectare under MIDH guidelines).

Public Health Implications: Efficacy, Safety, and Standardization

For consumers and medical practitioners, the government’s focus on Quality Planting Material (QPM) and standardized cultivation protocols addresses one of the longest-standing critiques of botanical medicine: variability in active constituent concentrations and potential contamination.

“When patients consume botanical preparations, therapeutic outcomes rely entirely on bio-active compound density—such as withanolides in Ashwagandha or bacosides in Brahmi,” explains Dr. Ananya Sharma, a senior public health analyst not involved in the government report. “Wild foraging often leads to batch-to-batch variation and heavy metal contamination due to unregulated soil conditions. Cultivating these crops under strict Good Agriculture Practices ensures batch consistency, purity, and trace-back accountability.”

                  RAW BOTANICAL QUALITY SPECTRUM
                  
  Wild / Unregulated Foraging              Standardized NMPB Cultivation
┌──────────────────────────────┐          ┌──────────────────────────────┐
│ ✘ High heavy-metal risk      │          │ ✓ Traceable soil safety      │
│ ✘ Inconsistent bio-actives   │   VS     │ ✓ Uniform active compounds   │
│ ✘ Ecological depletion       │          │ ✓ Sustainable harvesting     │
└──────────────────────────────┘          └──────────────────────────────┘

Moreover, integrating community-level processing hubs—equipped with proper drying, value-addition, and climate-controlled warehousing—prevents post-harvest fungal growth and mold toxins (aflatoxins), which frequently degrade raw botanical raw materials prior to formulation.

Challenges, Limitations, and Unanswered Questions

While the scheme demonstrates clear structural commitment, independent experts emphasize that financial allocation is only the first step. Several critical hurdles remain:

• Disparity in Fund Release: State-level data reveals uneven execution. For instance, while states like Delhi, Assam, and Tamil Nadu received substantial financial releases for Information Education & Communication (IEC) activities, others experienced significant gaps between approved amounts and actual fund disbursements.

• Market Price Volatility: Farmers shifting from traditional cereal crops to medicinal plants often face opaque pricing structures, as botanical markets can fluctuate wildly based on seasonal yields and buyer monopolies.

• Standardization Rigor: While GAPs are taught, monitoring thousands of small-holder farms for chemical pesticide residue remains a massive logistical undertaking.

What This Means for Consumers and Healthcare Providers

For the general public, this policy shift signals a gradual transformation in how botanical health products are grown and vetted:

1. Enhanced Quality and Safety: Over time, standardized farming practices mean retail herbal supplements will carry lower risks of heavy metal contamination and pesticide residues.

2. Support for Sustainable Sourcing: Consumers concerned about biodiversity can feel more assured that species like Kutki, Jatamansi, and Atees—which are vulnerable in the wild—are being conserved through systematic ex-situ plantations.

3. Clinical Integration: Healthcare providers utilizing integrative medical approaches can expect more predictable therapeutic profiles from phytomedicines derived from verified Quality Planting Materials.

As 57 distinct scientific R&D projects continue to evaluate the therapeutic parameters of these plants under government grants, the boundary between traditional botanical wisdom and rigorous agricultural science continues to narrow.

References

1. Ministry of Ayush, Government of India. (2026, July 21). Promotion of medicinal plants under NMPB. Press Information Bureau (PIB), Delhi. [Statement by Union Minister Prataprao Jadhav in Rajya Sabha].

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.